NAT10 and hepatocellular carcinoma: ELISA and WB analyses revealed that NAT10 knockdown significantly reduced TGF‐β1 and TGF‐β2 protein levels (Figure 4E,F), suggesting that NAT10 modulates HCC progression via TGF‐β signaling.